What is the frontotemporal dementia?
Atofying of temporary and frontal lobes of the brain, resulting in a permanent loss of function, is called Frontotemporal Dementia (FTD). This rare condition, formerly known as Pick's disease, is a discriminatory form of Alzheimer's disease. FrostotEmporal dementia, which has an adverse impact of the individual's personality, is a progressive disorder that is treated with medicines to slow its progression and handle symptoms. Although the condition may affect anyone in the middle or advanced age, people with a family history of Alzheimer's disease or dementia are considered an increased risk of being symptomatic. The ability of a person to function is primarily based on his behavior, motor skills and overall personality. Those who are diagnosed with frontotemporal degeneration of lobarůrience gradual loss of their neurological and motor skills. A well -known, deep impact of disease progression often requires assertive measures concerning planning long -term individual care.
The early onset of the disease often manifests itself as progressive changes in personality that affects a person's ability to be self -sufficient. Some people who have shown a strong and consistent work history suddenly cannot keep their jobs. Compulsive and inappropriate or aggressive behavior, significant mood changes or flat effects can often affect the individual's ability to interact with collaborators, friends and family. Some individuals who once left may begin to show introversion or recurring behavior that suppress their ability to maintain social connection.
In the end, behavior problems may be more complicated, because the ability of personcies will become disturbed. Many of them can find the speech or understanding of others' speech for difficult and lose the ability to communicate verbally or become. The gradual degeneration of language skills results in the inability to read, write and understand verbal andWritten communication. The procedure of neurological deficiencies further affects the ability of the individual to move and control its body functions. Cognitive shortcomings, which initially present themselves as a loss of periodic memory, are also deteriorating over time.
Reducing brain tissue associated with frontotemporal dementia, also known as the frontotemporal Lobar degeneration, is considered to be triggered by cell mutations. The original nickname, Pick's disease, was accepted more or less as an umbrella term for frontotemporal dementia. The key discovery based on the presentation and composition of cells contributed to the creation of the initial subtype of the frontotemporal dementia that would retain the name of Pick's disease. Different, subsequent discovered subtypes of frontotemporal dementia were completely classified on types of affected brain cells. Despite its subtype classifications, the symptoms and symptoms associated with frontotemporal degeneration of lobars are consistent across the components of its classifications based on cells; Although the severityBy presenting symptoms, it may vary dramatically from one individual to another.
When there is a suspicion of frontotemporal dementia, doctors generally order a battery of imaging tests and blood work to confirm the diagnosis. Searching for markers showing atrophic or degenerative tissue, computer tomography (CT) scan or magnetic resonance (MRI) of the brain can be performed. Blood work is used to assess the function of organs and hormone and chemical levels to exclude other conditions. In some cases, neurological testing can also be used, which includes the evaluation of cognitive abilities, namely the memory and information of RMACE.
If individuals with this type of dementia have been diagnosed with a basic or chronic condition such as heart disease or clinical depression, treatment is an existing condition. In some cases, the existence of a secondary state may contribute to the progression of the disease or the severity of the symptoms. Treatment of frontotemporal dementia timeThis involves administering drugs to slow down the disease progression. Antipsychotic and antidepressant drugs can be used to act against behavioral manifestations of frontotemporal degeneration of Lobar and stabilize the individual's mood, but their use for certain individuals brings significant risk. There is no cure for degeneration frontotemporal Lobar.